| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Apr 07, 2026 | Tax Payment (Shares) | $48.94 | 1,303 | 63,769 | 16,154 | Apr 08, 2026, 04:44 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Apr 07, 2026 | Option/RSU Exercise | - | 2,694 | - | 17,457 | Apr 08, 2026, 04:44 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Apr 01, 2026 | Tax Payment (Shares) | $48.13 | 2,510 | 120,806 | 14,763 | Apr 03, 2026, 04:40 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Apr 01, 2026 | Option/RSU Exercise | - | 5,187 | - | 17,273 | Apr 03, 2026, 04:40 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Mar 09, 2026 | Option/RSU Exercise | $20.69 | 36,722 | 759,804 | 48,808 | Mar 11, 2026, 04:38 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Mar 09, 2026 | Sale | $45.92 | 36,722 | 1,686,158 | 30,827 | Mar 11, 2026, 04:38 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Feb 09, 2026 | Sale | $43.28 | 17,845 | 772,254 | 20,817 | Feb 11, 2026, 04:38 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Feb 09, 2026 | Option/RSU Exercise | $13.87 | 10,845 | 150,371 | 29,931 | Feb 11, 2026, 04:38 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Jan 08, 2026 | Sale | $41.89 | 12,000 | 502,680 | 19,086 | Jan 09, 2026, 04:35 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Dec 08, 2025 | Option/RSU Exercise | $11.34 | 42,841 | 486,025 | 73,927 | Dec 10, 2025, 05:06 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Dec 08, 2025 | Sale | $41.49 | 42,841 | 1,777,473 | 31,086 | Dec 10, 2025, 05:06 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Nov 12, 2025 | Option/RSU Exercise | $30.93 | 19,900 | 615,507 | 50,986 | Nov 14, 2025, 04:35 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Nov 12, 2025 | Sale | $40.94 | 19,900 | 814,706 | 31,086 | Nov 14, 2025, 04:35 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Oct 28, 2025 | Option/RSU Exercise | $30.93 | 100 | 3,093 | 31,186 | Oct 30, 2025, 04:47 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Oct 28, 2025 | Sale | $41.00 | 100 | 4,100 | 31,086 | Oct 30, 2025, 04:47 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Sep 01, 2025 | Option/RSU Exercise | - | 6,036 | - | 33,045 | Sep 03, 2025, 04:45 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Sep 02, 2025 | Tax Payment (Shares) | $34.28 | 900 | 30,852 | 31,086 | Sep 03, 2025, 04:45 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Sep 02, 2025 | Option/RSU Exercise | - | 1,861 | - | 31,986 | Sep 03, 2025, 04:45 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Sep 01, 2025 | Tax Payment (Shares) | $33.49 | 2,920 | 97,791 | 30,125 | Sep 03, 2025, 04:45 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Aug 04, 2025 | Option/RSU Exercise | $22.89 | 18,889 | 432,369 | 45,898 | Aug 06, 2025, 04:30 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Aug 04, 2025 | Sale | $32.89 | 18,889 | 621,259 | 27,009 | Aug 06, 2025, 04:30 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Jun 03, 2025 | Option/RSU Exercise | $18.00 | 18,299 | 329,382 | 45,308 | Jun 05, 2025, 04:38 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Jun 03, 2025 | Sale | $28.80 | 18,299 | 527,011 | 27,009 | Jun 05, 2025, 04:38 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Apr 29, 2025 | Option/RSU Exercise | $15.51 | 42,000 | 651,400 | 69,009 | May 01, 2025, 06:24 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Apr 29, 2025 | Sale | $25.61 | 42,000 | 1,075,620 | 27,009 | May 01, 2025, 06:24 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Apr 30, 2025 | Option/RSU Exercise | $16.90 | 21,254 | 359,193 | 48,263 | May 01, 2025, 06:24 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Apr 30, 2025 | Sale | $26.95 | 21,254 | 572,795 | 27,009 | May 01, 2025, 06:24 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | May 01, 2025 | Option/RSU Exercise | $17.84 | 25,141 | 448,424 | 52,150 | May 01, 2025, 06:24 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | May 01, 2025 | Sale | $27.80 | 25,141 | 698,920 | 27,009 | May 01, 2025, 06:24 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Apr 26, 2025 | Tax Payment (Shares) | $21.36 | 479 | 10,234 | 27,009 | Apr 29, 2025, 04:34 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Apr 26, 2025 | Option/RSU Exercise | - | 990 | - | 27,488 | Apr 29, 2025, 04:34 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Apr 07, 2025 | Tax Payment (Shares) | $20.28 | 1,303 | 26,425 | 26,498 | Apr 09, 2025, 04:45 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Apr 07, 2025 | Option/RSU Exercise | - | 2,694 | - | 27,801 | Apr 09, 2025, 04:45 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Apr 01, 2025 | Option/RSU Exercise | - | 3,342 | - | 26,724 | Apr 03, 2025, 05:04 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Apr 01, 2025 | Tax Payment (Shares) | $21.77 | 1,617 | 35,202 | 25,877 | Apr 03, 2025, 05:04 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Mar 20, 2025 | Option/RSU Exercise | $12.97 | 15,944 | 206,794 | 39,326 | Mar 24, 2025, 04:35 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Mar 20, 2025 | Sale | $23.11 | 15,944 | 368,466 | 23,382 | Mar 24, 2025, 04:35 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Mar 19, 2025 | Option/RSU Exercise | $12.97 | 8,879 | 115,161 | 32,261 | Mar 19, 2025, 05:53 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Mar 16, 2025 | Tax Payment (Shares) | $22.61 | 448 | 10,129 | 23,382 | Mar 19, 2025, 05:53 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Mar 19, 2025 | Sale | $23.10 | 8,879 | 205,105 | 23,382 | Mar 19, 2025, 05:53 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Mar 16, 2025 | Option/RSU Exercise | - | 872 | - | 23,830 | Mar 19, 2025, 05:53 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Mar 17, 2025 | Option/RSU Exercise | $12.97 | 11,464 | 148,688 | 34,846 | Mar 19, 2025, 05:53 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Mar 17, 2025 | Sale | $23.10 | 11,464 | 264,818 | 23,382 | Mar 19, 2025, 05:53 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Mar 12, 2025 | Sale | $22.25 | 36,372 | 809,277 | 22,958 | Mar 14, 2025, 04:37 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Mar 12, 2025 | Option/RSU Exercise | $11.97 | 36,372 | 435,373 | 59,330 | Mar 14, 2025, 04:37 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Dec 06, 2024 | Option/RSU Exercise | $10.76 | 2,406 | 25,889 | 25,364 | Dec 10, 2024, 04:34 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Dec 06, 2024 | Sale | $21.27 | 8,969 | 190,771 | 22,958 | Dec 10, 2024, 04:34 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Dec 09, 2024 | Option/RSU Exercise | $11.10 | 18,860 | 209,346 | 41,818 | Dec 10, 2024, 04:34 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Dec 09, 2024 | Sale | $21.38 | 18,860 | 403,227 | 22,958 | Dec 10, 2024, 04:34 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Dec 03, 2024 | Option/RSU Exercise | $10.76 | 8,969 | 96,506 | 31,927 | Dec 05, 2024, 07:14 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Dec 03, 2024 | Sale | $21.45 | 8,969 | 192,385 | 22,958 | Dec 05, 2024, 07:14 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Dec 04, 2024 | Option/RSU Exercise | $10.76 | 5,024 | 54,058 | 27,982 | Dec 05, 2024, 07:14 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Dec 04, 2024 | Sale | $21.25 | 5,024 | 106,760 | 22,958 | Dec 05, 2024, 07:14 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Dec 05, 2024 | Option/RSU Exercise | $10.76 | 1,123 | 12,083 | 24,081 | Dec 05, 2024, 07:14 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Dec 05, 2024 | Sale | $21.25 | 1,123 | 23,864 | 22,958 | Dec 05, 2024, 07:14 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Sep 01, 2024 | Tax Payment (Shares) | $26.74 | 2,260 | 60,432 | 22,053 | Sep 04, 2024, 08:51 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Sep 01, 2024 | Option/RSU Exercise | - | 4,444 | - | 24,313 | Sep 04, 2024, 08:51 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Sep 02, 2024 | Tax Payment (Shares) | $26.74 | 956 | 25,563 | 22,958 | Sep 04, 2024, 08:51 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Sep 02, 2024 | Option/RSU Exercise | - | 1,861 | - | 23,914 | Sep 04, 2024, 08:51 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Jul 23, 2024 | Sale | $24.79 | 24,248 | 601,108 | 19,253 | Jul 25, 2024, 04:32 PM |
| KNSA | | Kiniksa Pharmaceuticals International, plc | Mark Ragosa | CHIEF FINANCIAL OFFICER | Jul 23, 2024 | Option/RSU Exercise | $11.10 | 24,248 | 269,153 | 43,501 | Jul 25, 2024, 04:32 PM |
| KNSA | | Kiniksa Pharmaceuticals, Ltd. | Mark Ragosa | CHIEF FINANCIAL OFFICER | Apr 26, 2024 | Tax Payment (Shares) | $17.88 | 509 | 9,101 | 19,253 | Apr 30, 2024, 04:35 PM |
| KNSA | | Kiniksa Pharmaceuticals, Ltd. | Mark Ragosa | CHIEF FINANCIAL OFFICER | Apr 26, 2024 | Option/RSU Exercise | - | 991 | - | 19,762 | Apr 30, 2024, 04:35 PM |
| KNSA | | Kiniksa Pharmaceuticals, Ltd. | Mark Ragosa | CHIEF FINANCIAL OFFICER | Apr 08, 2024 | Tax Payment (Shares) | $17.90 | 791 | 14,159 | 18,771 | Apr 08, 2024, 05:20 PM |
| KNSA | | Kiniksa Pharmaceuticals, Ltd. | Mark Ragosa | CHIEF FINANCIAL OFFICER | Apr 08, 2024 | Option/RSU Exercise | - | 2,694 | - | 19,562 | Apr 08, 2024, 05:20 PM |
| KNSA | | Kiniksa Pharmaceuticals, Ltd. | Mark Ragosa | CHIEF FINANCIAL OFFICER | Apr 01, 2024 | Tax Payment (Shares) | $19.70 | 514 | 10,126 | 16,868 | Apr 03, 2024, 05:25 PM |
| KNSA | | Kiniksa Pharmaceuticals, Ltd. | Mark Ragosa | CHIEF FINANCIAL OFFICER | Apr 01, 2024 | Option/RSU Exercise | - | 1,750 | - | 17,382 | Apr 03, 2024, 05:25 PM |
| KNSA | | Kiniksa Pharmaceuticals, Ltd. | Mark Ragosa | CHIEF FINANCIAL OFFICER | Jan 03, 2024 | Option/RSU Exercise | $8.83 | 12,000 | 105,960 | 27,632 | Jan 04, 2024, 04:30 PM |
| KNSA | | Kiniksa Pharmaceuticals, Ltd. | Mark Ragosa | CHIEF FINANCIAL OFFICER | Jan 03, 2024 | Sale | $20.00 | 12,000 | 240,000 | 15,632 | Jan 04, 2024, 04:30 PM |
| KNSA | | Kiniksa Pharmaceuticals, Ltd. | Mark Ragosa | CHIEF FINANCIAL OFFICER | Sep 02, 2023 | Tax Payment (Shares) | $17.76 | 547 | 9,715 | 15,632 | Sep 06, 2023, 07:06 PM |
| KNSA | | Kiniksa Pharmaceuticals, Ltd. | Mark Ragosa | CHIEF FINANCIAL OFFICER | Sep 02, 2023 | Option/RSU Exercise | - | 1,861 | - | 16,179 | Sep 06, 2023, 07:06 PM |
| KNSA | | Kiniksa Pharmaceuticals, Ltd. | Mark Ragosa | CHIEF FINANCIAL OFFICER | Sep 01, 2023 | Tax Payment (Shares) | $17.76 | 791 | 14,048 | 14,318 | Sep 06, 2023, 07:06 PM |
| KNSA | | Kiniksa Pharmaceuticals, Ltd. | Mark Ragosa | CHIEF FINANCIAL OFFICER | Sep 01, 2023 | Option/RSU Exercise | - | 2,695 | - | 15,109 | Sep 06, 2023, 07:06 PM |
| KNSA | | Kiniksa Pharmaceuticals, Ltd. | Mark Ragosa | CHIEF FINANCIAL OFFICER | Apr 26, 2023 | Tax Payment (Shares) | $11.15 | 291 | 3,245 | 12,414 | Apr 28, 2023, 04:15 PM |
| KNSA | | Kiniksa Pharmaceuticals, Ltd. | Mark Ragosa | CHIEF FINANCIAL OFFICER | Apr 26, 2023 | Option/RSU Exercise | - | 990 | - | 12,705 | Apr 28, 2023, 04:15 PM |
| KNSA | | Kiniksa Pharmaceuticals, Ltd. | Mark Ragosa | CHIEF FINANCIAL OFFICER | Apr 10, 2023 | Option/RSU Exercise | - | 2,695 | - | 12,506 | Apr 11, 2023, 05:04 PM |
| KNSA | | Kiniksa Pharmaceuticals, Ltd. | Mark Ragosa | CHIEF FINANCIAL OFFICER | Apr 10, 2023 | Tax Payment (Shares) | $10.71 | 791 | 8,472 | 11,715 | Apr 11, 2023, 05:04 PM |
| KNSA | | Kiniksa Pharmaceuticals, Ltd. | Mark Ragosa | CHIEF FINANCIAL OFFICER | Mar 16, 2023 | Tax Payment (Shares) | $11.46 | 256 | 2,934 | 8,287 | Mar 20, 2023, 05:14 PM |
| KNSA | | Kiniksa Pharmaceuticals, Ltd. | Mark Ragosa | CHIEF FINANCIAL OFFICER | Mar 16, 2023 | Option/RSU Exercise | - | 872 | - | 8,543 | Mar 20, 2023, 05:14 PM |
| KNSA | | Kiniksa Pharmaceuticals, Ltd. | Mark Ragosa | CHIEF FINANCIAL OFFICER | Mar 20, 2023 | Tax Payment (Shares) | $11.12 | 634 | 7,050 | 9,811 | Mar 20, 2023, 05:14 PM |
| KNSA | | Kiniksa Pharmaceuticals, Ltd. | Mark Ragosa | CHIEF FINANCIAL OFFICER | Mar 20, 2023 | Option/RSU Exercise | - | 2,158 | - | 10,445 | Mar 20, 2023, 05:14 PM |
| KNSA | | Kiniksa Pharmaceuticals, Ltd. | Mark Ragosa | CHIEF FINANCIAL OFFICER | Sep 02, 2022 | Tax Payment (Shares) | $11.44 | 547 | 6,258 | 7,671 | Sep 06, 2022, 04:10 PM |
| KNSA | | Kiniksa Pharmaceuticals, Ltd. | Mark Ragosa | CHIEF FINANCIAL OFFICER | Sep 02, 2022 | Option/RSU Exercise | - | 1,861 | - | 8,218 | Sep 06, 2022, 04:10 PM |
| KNSA | | Kiniksa Pharmaceuticals, Ltd. | Mark Ragosa | CHIEF FINANCIAL OFFICER | Apr 26, 2022 | Tax Payment (Shares) | $9.99 | 282 | 2,817 | 6,357 | Apr 28, 2022, 04:31 PM |
| KNSA | | Kiniksa Pharmaceuticals, Ltd. | Mark Ragosa | CHIEF FINANCIAL OFFICER | Apr 26, 2022 | Option/RSU Exercise | - | 991 | - | 6,639 | Apr 28, 2022, 04:31 PM |
| KNSA | | Kiniksa Pharmaceuticals, Ltd. | Mark Ragosa | CHIEF FINANCIAL OFFICER | Mar 21, 2022 | Tax Payment (Shares) | $10.98 | 1,047 | 11,496 | 5,648 | Mar 23, 2022, 04:30 PM |
| KNSA | | Kiniksa Pharmaceuticals, Ltd. | Mark Ragosa | CHIEF FINANCIAL OFFICER | Mar 21, 2022 | Option/RSU Exercise | - | 3,019 | - | 6,695 | Mar 23, 2022, 04:30 PM |
| KNSA | | Kiniksa Pharmaceuticals, Ltd. | Mark Ragosa | Chief Financial Officer | Mar 16, 2022 | Tax Payment (Shares) | $10.13 | 303 | 3,069 | 3,676 | Mar 18, 2022, 04:38 PM |
| KNSA | | Kiniksa Pharmaceuticals, Ltd. | Mark Ragosa | Chief Financial Officer | Mar 16, 2022 | Option/RSU Exercise | - | 872 | - | 3,979 | Mar 18, 2022, 04:38 PM |
| KNSA | | Kiniksa Pharmaceuticals, Ltd. | Mark Ragosa | Interim CFO | Dec 31, 2020 | Tax Payment (Shares) | $17.67 | 1,297 | 22,918 | 3,107 | Jan 05, 2021, 05:07 PM |
| KNSA | | Kiniksa Pharmaceuticals, Ltd. | Mark Ragosa | Interim CFO | Dec 31, 2020 | Option/RSU Exercise | - | 4,404 | - | 4,404 | Jan 05, 2021, 05:07 PM |